Growth leadership Recent C-suite hires including a new Chief Executive Officer and Chief Product Officer signal a growth-oriented roadmap, presenting an opening to align with strategic initiatives, enterprise partnerships, and platform expansion opportunities.

Expansion potential Awards and partnerships in 2025-2026 highlight momentum in digital platform development and site operations enhancements, indicating readiness for deeper integrations, channel collaborations, and co-marketing arrangements with CROs, sponsors, and site networks.

Platform focus The eClinical platform emphasizes site-centric workflows beyond traditional CTMS, suggesting opportunities to upsell modular modules, data integration services, and streamlined enrollment capabilities to accelerate trial timelines.

Financial scale With estimated revenue in the mid-range tens of millions and a mid-size employee base, there is potential for scalable enterprise contracts, long-term support arrangements, and multi-site deployment deals with sponsors seeking standardized solutions.

Industry momentum Recognition in Clinical Trials Arena awards and senior-level leadership appointments position RealTime as a credible partner in the clinical trials tech ecosystem, creating openings for strategic partnerships, case studies, and referenceable customers to drive new business.